Adjuvant therapy in node-positive vulvar cancer

References

• Beller U, Quinn MA, Benedet JL et al. Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet. 95(Suppl. 1), S7–27 (2006).
   PubMed Web of Science ®Google Scholar
• Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet. Gynecol. 107(5), 1018–1022 (2006).
   PubMed Web of Science ®Google Scholar
• Hampl M, Kueppers V, Bender HG. Single large inguinal lymph node metastasis in human papillomavirus-induced early invasive vulvar cancer of the anterior fourchette in two young women. Gynecol. Obstet. Invest. 67(1), 42–45 (2009).
   PubMedGoogle Scholar
• Joura EA, Lösch A, Haider-Angeler MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J. Reprod. Med. 45(8), 613–615 (2000).
   PubMed Web of Science ®Google Scholar
• Messing MJ, Gallup DG. Carcinoma of the vulva in young women. Obstet. Gynecol. 86(1), 51–54 (1995).
   PubMed Web of Science ®Google Scholar
• Hampl M, Hantschmann P, Michels W, Hillemanns P; German Multicenter Study Group. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol. Oncol. 111(2), 282–288 (2008).
   PubMed Web of Science ®Google Scholar
• Beriwal S, Coon D, Heron DE et al. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecol. Oncol. 109(2), 291–295 (2008).
   PubMed Web of Science ®Google Scholar
• Jhingran A. Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies. Semin. Radiat. Oncol. 16(3), 144–151 (2006).
   PubMedGoogle Scholar
• Moran MS, Castrucci WA, Ahmad M et al. Clinical utility of the modified segmental boost technique for treatment of the pelvis and inguinal nodes. Int. J. Radiat. Oncol. Biol. Phys. 76(4), 1026–1036 (2010).
   PubMedGoogle Scholar
• Faul CM, Mirmow D, Huang Q, Gerszten K, Day R, Jones MW. Adjuvant radiation for vulvar carcinoma: improved local control. Int. J. Radiat. Oncol. Biol. Phys. 38(2), 381–389 (1997).
   PubMedGoogle Scholar
• Wittekind C, Meyer HJ, Bootz F, Wagner G. TNM Klassifikation Maligner Tumoren. Springer, Berlin, Germany (2002).
   Google Scholar
• DiSaia PJ, Creasman WT, Rich WM. An alternate approach to early cancer of the vulva. Am. J. Obstet. Gynecol. 133(7), 825–832 (1979).
   PubMed Web of Science ®Google Scholar
• Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol. Oncol. 57(2), 215–220 (1995).
   PubMed Web of Science ®Google Scholar
• Kunos C, Simpkins F, Gibbons H, Tian C, Homesley H. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet. Gynecol. 114(3), 537–546 (2009).
   PubMedGoogle Scholar
• Woelber L, Choschzick M, Eulenburg C et al. Prognostic value of pathological resection margin distance in squamous cell cancer of the vulva. Ann. Surg. Oncol. 18(13), 3811–3818 (2011).
   PubMed Web of Science ®Google Scholar
• Chan JK, Sugiyama V, Pham H et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol. Oncol. 104(3), 636–641 (2007).
   PubMed Web of Science ®Google Scholar
• Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol. Oncol. 57(2), 215–220 (1995).
   PubMed Web of Science ®Google Scholar
• De Hullu JA, Hollema H, Lolkema S et al. Vulvar carcinoma. The price of less radical surgery. Cancer 95(11), 2331–2338 (2002).
   PubMed Web of Science ®Google Scholar
• Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol. Oncol. 38(3), 309–314 (1990).
   PubMed Web of Science ®Google Scholar
• Groenen SM, Timmers PJ, Burger CW. Recurrence rate in vulvar carcinoma in relation to pathological margin distance. Int. J. Gynecol. Cancer 20(5), 869–873 (2010).
   PubMed Web of Science ®Google Scholar
• Höckel M, Schmidt K, Bornmann K, Horn LC, Dornhöfer N. Vulvar field resection: novel approach to the surgical treatment of vulvar cancer based on ontogenetic anatomy. Gynecol. Oncol. 119(1), 106–113 (2010).
   PubMedGoogle Scholar
• Catanzarite T, Neubauer N, Doll K, Singh D, Schink J, Lurain J. Margin status as predictor of recurrence in squamous cell carcinoma of the vulva: challenging the 8 millimeter rule. IGCS, Vancouver, BC, Canada (2012).
   Google Scholar
• Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol. Oncol. 57(3), 327–334 (1995).
   PubMed Web of Science ®Google Scholar
• Woelber L, Mahner S, Voelker K et al. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res. 29(2), 545–552 (2009).
   PubMed Web of Science ®Google Scholar
• Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int. J. Radiat. Oncol. Biol. Phys. 57(2), 409–418 (2003).
   PubMed Web of Science ®Google Scholar
• Tantipalakorn C, Robertson G, Marsden DE, Gebski V, Hacker NF. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet. Gynecol. 113(4), 895–901 (2009).
   PubMed Web of Science ®Google Scholar
• Rouzier R, Haddad B, Plantier F, Dubois P, Pelisse M, Paniel BJ. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet. Gynecol. 100(6), 1159–1167 (2002).
   PubMed Web of Science ®Google Scholar
• Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit. Rev. Oncol. Hematol. 60(3), 227–241 (2006).
   PubMed Web of Science ®Google Scholar
• Woelber L, Mahner S, Voelker K et al. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res. 29(2), 545–552 (2009).
   PubMed Web of Science ®Google Scholar
• Stehman FB, Bundy BN, Thomas G et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int. J. Radiat. Oncol. Biol. Phys. 24(2), 389–396 (1992).
   PubMed Web of Science ®Google Scholar
• Oonk MH, van Hemel BM, Hollema H et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 11(7), 646–652 (2010).
   PubMed Web of Science ®Google Scholar
• van der Velden J, van Lindert AC, Lammes FB et al. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer 75(12), 2885–2890 (1995).
   PubMed Web of Science ®Google Scholar
• Lataifeh I, Nascimento MC, Nicklin JL, Perrin LC, Crandon AJ, Obermair A. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol. Oncol. 95(3), 701–705 (2004).
   PubMed Web of Science ®Google Scholar
• Paladini D, Cross P, Lopes A, Monaghan JM. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. Cancer 74(9), 2491–2496 (1994).
   PubMed Web of Science ®Google Scholar
• Origoni M, Sideri M, Garsia S, Carinelli SG, Ferrari AG. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol. Oncol. 45(3), 313–316 (1992).
   PubMed Web of Science ®Google Scholar
• Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet. Gynecol. 68(6), 733–740 (1986).
   PubMed Web of Science ®Google Scholar
• Fons G, Groenen SM, Oonk MH et al. Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol. Oncol. 114(2), 343–345 (2009).
   PubMed Web of Science ®Google Scholar
• Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet. Gynecol. 61(4), 408–412 (1983).
   PubMedGoogle Scholar
• Curry SL, Wharton JT, Rutledge F. Positive lymph nodes in vulvar squamous carcinoma. Gynecol. Oncol. 9(1), 63–67 (1980).
   PubMed Web of Science ®Google Scholar
• Klemm P, Marnitz S, Köhler C, Braig U, Schneider A. Clinical implication of laparoscopic pelvic lymphadenectomy in patients with vulvar cancer and positive groin nodes. Gynecol. Oncol. 99(1), 101–105 (2005).
   PubMedGoogle Scholar
• Oonk MH, de Hullu JA, van der Zee AG. Current controversies in the management of patients with early-stage vulvar cancer. Curr. Opin. Oncol. 22(5), 481–486 (2010).
   PubMed Web of Science ®Google Scholar
• Knopp S, Holm R, Tropé C, Nesland JM. Occult lymph node metastases in early stage vulvar carcinoma patients. Gynecol. Oncol. 99(2), 383–387 (2005).
   PubMedGoogle Scholar
• Narayansingh GV, Miller ID, Sharma M et al. The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva. Br. J. Cancer 92(2), 222–224 (2005).
   PubMedGoogle Scholar
• Woelber L, Eulenburg C, Choschzick M et al. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int. J. Gynecol. Cancer 22(3), 503–508 (2012).
   PubMed Web of Science ®Google Scholar
• Parthasarathy A, Cheung MK, Osann K et al. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol. Oncol. 103(3), 1095–1099 (2006).
   PubMed Web of Science ®Google Scholar
• Mahner S, Jueckstock JK, Hilpert F et al. Impact of adjuvant therapy in lymph-node positive vulvar cancer: The AGO CARE 1 study. J. Clin. Oncol. 30(Suppl.), Abstract 5007 (2012).
   Google Scholar
• Bellati F, Angioli R, Manci N et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol. Oncol. 96(1), 227–231 (2005).
   PubMed Web of Science ®Google Scholar
• Han SC, Kim DH, Higgins SA, Carcangiu ML, Kacinski BM. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int. J. Radiat. Oncol. Biol. Phys. 47(5), 1235–1244 (2000).
   PubMedGoogle Scholar
• Moore DH, Koh WJ, McGuire WP, EJ W. Vulva. In: Principles and Practices of Gynecologic Cancers. Hoskins WJ, Perez CA, Young RC, Barakat RR, Markman M, Randall ME (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, USA (2005).
   Google Scholar
• Hoffman MS. Squamous-cell carcinoma of the vulva: locally advanced disease. Best Pract. Res. Clin. Obstet. Gynaecol. 17(4), 635–647 (2003).
   PubMedGoogle Scholar
• Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a Phase II study of the Gynecologic Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 42(1), 79–85 (1998).
   PubMed Web of Science ®Google Scholar
• Moore DH, Ali S, Koh WJ et al. A Phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study. Gynecol. Oncol. 124(3), 529–533 (2012).
   PubMed Web of Science ®Google Scholar